July 26, 2023

BIRD Foundation invests $8 million in 9 new projects

James Spiro

The approved projects, with an overall budget of $23 million, touch on agritech, biotech, electronics, foodtech, medical devices, and quantum technology

 

 

The Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation has announced that it has approved $8 million in funding for nine new projects between U.S. and Israeli companies. Alongside grants from BIRD, the projects will access private-sector funding and boost the total investment in all projects to $23 million.
As well as conditional grants of up to $1.5 million, the BIRD Foundation assists by working with companies to identify potential strategic partners and facilitate introductions.
 
The submitted projects are reviewed by evaluators appointed by the National Institute of Standards and Technology (NIST) of the U.S. Department of Commerce and the Israel Innovation Authority. They are as follows:
 
  • Agado Live (from Tel Aviv) and Adventist HealthCare (from Rockville – which will develop an end-to-end remote rehabilitation platform for neurologic diseases.
  • Agromentum (dba as Fieldin) (from Yokneam Illit) and Manulife Investment Management Agriculture Services Inc. (from Turlock, CA) – which will develop a hardware and software platform that turns tractors autonomous for operating in orchards.
  • AlvaLinks (from Tel Aviv) and Cobalt Digital (from Champaign, IL) – which will develop a video network intelligence and observability platform for broadcasting and media companies.
  • ContainerEyes (from Tel Aviv) and NTELX (from Tysons, VA) – which will develop a real-time tracking and risk analysis service to improve food safety and reduce food loss when shipped.
  • Geneyx (from Herzliya) and Ocean Genomics (from Pittsburgh, PA) – which will develop a multi-omic software method, combining DNA and RNA, improving the detection of genomic variants to improve the diagnosis of diseases and the identification of drug targets.
  • NeuroTrigger (from Tel Aviv) and Rand Eye Institute (from Deerfield Beach, FL) – which will develop a clinically validated eyelid pacemaker that restores blinking to those with facial paralysis.
  • Oshi (from Rehovot) and The Better Meat Co. (from West Sacramento, CA) – which will develop allergen-free mycelium-based whole-cut salmon analogs.
  • Quantum Machines (from Tel Aviv) and QuEra Computing Inc. (from Boston, MA) – which will develop a Photonic Control Unit and Photonic Integrated Circuit that will be incorporated into quantum computing devices.
  • Treetoscope (from Mikve) and The Toro Company (from Minneapolis, MN) – which will develop next-generation cost-effective and scalable precision irrigation management based on direct plant sensing technology.
 
“As the new Executive Director of the BIRD Foundation, it was important for me to keep the fund’s investments at the forefront of technological development,” said Jaron Lotan. “This cycle, we received a record number of outstanding submissions, and our BIRD team provided exceptional assistance to the companies. I am proud of the diverse and high-quality companies collaborating to develop creative solutions for future technologies, and I wish them much success in their efforts to bring new and innovative products to market.”
The BIRD Foundation promotes collaborations between U.S. and Israeli companies in various technological sectors for joint product development. provides funding of up to 50% of a project’s budget, beginning with R&D and ending with the initial stages of sales and marketing. The Foundation shares the risk and does not require repayment if the project fails to reach the sales stage.
 

Additional Articles

News

Geneyx Among the World's Best Digital Health Companies in 2024

May 15, 2024

Geneyx Among the World’s Best Digital Health Companies in 2024

Newsweek

This acknowledgment highlights Geneyx's significant contributions to the rapidly expanding digital health sector.

Children's Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis

March 13, 2024

Children’s Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis

PR Newswire

Children's Mercy Kansas City, one of the leading independent pediatric health organizations, and Geneyx Inc. are pleased to announce a collaboration aimed at advancing genomic research and analysis.

PacBio Geneyx Press Release

November 1, 2023

PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partner Geneyx to PacBio Compatible

PacBio

Partnerships maximize value of HiFi data and complete the full end-to-end workflow for PacBio customers.

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

July 26, 2023

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

Geneyx

Geneyx and Ocean Genomics develop a multiomic software method, combining DNA and RNA.

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

July 26, 2023

BIRD Foundation invests $8 million in 9 new projects

James Spiro

Geneyx and Ocean Genomics will develop a multiomic software method, combining DNA and RNA.

Bioinformatics Startup Geneyx Builds Business on Whole-Genome, Long-Read Sequencing Analysis

June 21, 2023

Bioinformatics Startup Geneyx Builds Business on Whole-Genome, Long-Read Sequencing Analysis

Neil Versel

This month's announcement that Oxford Nanopore Technologies would integrate its Epi2Me cloud-based analysis platform with Geneyx's software to automate analysis and clinical reporting of long-read sequencing data

Previous
Next
Geneyx Among the World's Best Digital Health Companies in 2024

May 15, 2024

Geneyx Among the World’s Best Digital Health Companies in 2024

Newsweek

This acknowledgment highlights Geneyx's significant contributions to the rapidly expanding digital health sector.

Children's Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis

March 13, 2024

Children’s Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis

PR Newswire

Children's Mercy Kansas City, one of the leading independent pediatric health organizations, and Geneyx Inc. are pleased to announce a collaboration aimed at advancing genomic research and analysis.

PacBio Geneyx Press Release

November 1, 2023

PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partner Geneyx to PacBio Compatible

PacBio

Partnerships maximize value of HiFi data and complete the full end-to-end workflow for PacBio customers.

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

July 26, 2023

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

Geneyx

Geneyx and Ocean Genomics develop a multiomic software method, combining DNA and RNA.

Geneyx and Ocean Genomics Collaborate to Enhance Genomic Variant Detection for Improved Disease Diagnosis and Drug Target Identification

July 26, 2023

BIRD Foundation invests $8 million in 9 new projects

James Spiro

Geneyx and Ocean Genomics will develop a multiomic software method, combining DNA and RNA.

Bioinformatics Startup Geneyx Builds Business on Whole-Genome, Long-Read Sequencing Analysis

June 21, 2023

Bioinformatics Startup Geneyx Builds Business on Whole-Genome, Long-Read Sequencing Analysis

Neil Versel

This month's announcement that Oxford Nanopore Technologies would integrate its Epi2Me cloud-based analysis platform with Geneyx's software to automate analysis and clinical reporting of long-read sequencing data

+

Selected Videos

Geneyx Analysis Version 5.12 Release

Previous
Next

Schedule Demo

Contact us to set a live demo


Contact Us

Whether you have general questions about our solutions or would like to schedule a demo or to suggest collaboration – our team is on hand for you.